Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Veno-occlusive Disease”

419 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 419 results

Not applicableLooking for participantsNCT01496625
What this trial is testing

National Eye Institute Biorepository for Retinal Diseases

Who this might be right for
Age-Related Macular DegenerationDiabetic RetinopathyVon Hippel-Lindau Syndrome+2 more
National Eye Institute (NEI) 650
Not applicableStudy completedNCT02759276
What this trial is testing

Microcirculation and Inflammatory Markers in Patients With Resistant, Stages 1/2 Hypertension and Normal Blood Pressure

Who this might be right for
High Blood Pressure
Daniel Alexandre Bottino 75
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Not applicableLooking for participantsNCT07095660
What this trial is testing

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)

Who this might be right for
Venous Obstruction
Intervene, Inc. 20
Post-approval studies (Phase 4)Study completedNCT06416241
What this trial is testing

Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionVascular Occlusive Disease
University of Athens 51
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Early research (Phase 1)Study completedNCT05277922
What this trial is testing

Effect of C21 on Forearm Blood Flow

Who this might be right for
Study Vasodilatory Effects of C21
Vicore Pharma AB 5
Large-scale testing (Phase 3)UnknownNCT06572553
What this trial is testing

Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients

Who this might be right for
Age-Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Testing effectiveness (Phase 2)Ended earlyNCT00211471
What this trial is testing

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Who this might be right for
Severe Diabetic RetinopathyCentral Retinal Vein OcclusionChronic Inflammation+1 more
Manhattan Eye, Ear & Throat Hospital
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Post-approval studies (Phase 4)Study completedNCT01027481
What this trial is testing

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Medical University of Vienna 30
Not applicableStudy completedNCT01282411
What this trial is testing

Anatomic Outcomes Following Ozurdex Injections

Who this might be right for
Retinal Vein Occlusions
Barnes Retina Institute 10
Not applicableStudy completedNCT00952614
What this trial is testing

A Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Glenn Jaffe 29
Not applicableEnded earlyNCT04514406
What this trial is testing

APERTO CVS PMCF Study

Who this might be right for
Dialysis; ComplicationsCentral Vein ObstructionStenosis+1 more
Cardionovum GmbH 6
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Ended earlyNCT00500045
What this trial is testing

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Who this might be right for
Central Retinal Vein OcclusionBranch Retinal Vein Occlusion
Palo Alto Medical Foundation 36
Post-approval studies (Phase 4)Study completedNCT02274259
What this trial is testing

Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen

Who this might be right for
Central Retinal Vein Occlusion
Anders Kvanta 40
Not applicableUnknownNCT02505152
What this trial is testing

Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy

Who this might be right for
Hypertension, PortalPortal Vein, Cavernous Transformation Of
Sun Yat-sen University 50
Not applicableUnknownNCT04142164
What this trial is testing

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Who this might be right for
Age-related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Prim. Prof. Dr. Oliver Findl, MBA 40
Load More Results